|
DE3775830D1
(de)
*
|
1986-06-13 |
1992-02-20 |
Alza Corp |
Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
|
|
US5176917A
(en)
*
|
1989-03-15 |
1993-01-05 |
Lts Lohmann |
Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
|
|
US5116620A
(en)
*
|
1989-11-21 |
1992-05-26 |
Bruce A. Barber |
Antimicrobial wound dressing
|
|
US5227168A
(en)
*
|
1989-11-21 |
1993-07-13 |
Bruce Barber |
Method of treating a wound
|
|
US5104660A
(en)
*
|
1989-11-21 |
1992-04-14 |
Bruce A. Barber |
Method of preparing an antimicrobial wound dressing
|
|
US5443727A
(en)
*
|
1990-10-30 |
1995-08-22 |
Minnesota Mining And Manufacturing Company |
Articles having a polymeric shell and method for preparing same
|
|
US6132849A
(en)
*
|
1990-10-30 |
2000-10-17 |
Minnesota Mining And Manufacturing Company |
Receptive media for permanent imaging and methods of preparing and using same
|
|
CA2076574A1
(en)
*
|
1991-10-01 |
1993-04-02 |
John Lenneis Haynes |
Extended-life drug filled patch
|
|
CA2187023A1
(en)
*
|
1994-04-13 |
1995-10-26 |
Steven Andrew Giannos |
Temporally controlled drug delivery systems
|
|
GB9515807D0
(en)
*
|
1995-08-02 |
1995-10-04 |
Cantwell Evelyna D |
Topical hyperbaric bandage
|
|
US5730721A
(en)
*
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
|
US20060002949A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
|
US20060002959A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Government Of The United States |
Skin-sctive adjuvants for transcutaneous immuization
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
US6019997A
(en)
*
|
1997-01-09 |
2000-02-01 |
Minnesota Mining And Manufacturing |
Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
|
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
|
US20040258703A1
(en)
*
|
1997-11-14 |
2004-12-23 |
The Government Of The Us, As Represented By The Secretary Of The Army |
Skin-active adjuvants for transcutaneous immunization
|
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
|
US20050197283A1
(en)
*
|
1998-10-04 |
2005-09-08 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
|
|
IL126447A
(en)
*
|
1998-10-04 |
2004-09-27 |
Vascular Biogenics Ltd |
An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
|
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
|
ES2336054T3
(es)
|
1998-12-18 |
2010-04-07 |
Alza Corporation |
Dispositivo transparente para la administracion transdermica de nicotina.
|
|
AU2998900A
(en)
*
|
1999-02-19 |
2000-09-04 |
Leslee S. Brooks |
Zinc chloride in treating skin diseases
|
|
US6337328B1
(en)
|
1999-03-01 |
2002-01-08 |
Sepracor, Inc. |
Bupropion metabolites and methods of use
|
|
EP1169025B1
(en)
*
|
1999-04-01 |
2005-08-24 |
Alza Corporation |
Transdermal drug delivery devices comprising a polyurethane drug reservoir
|
|
AU4188100A
(en)
*
|
1999-04-08 |
2000-11-14 |
Gregory M. Glenn |
Dry formulation for transcutaneous immunization
|
|
US6812205B2
(en)
|
2000-03-15 |
2004-11-02 |
The Brigham & Women's Hospital, Inc. |
Suppression of vascular disorders by mucosal administration of heat shock protein peptides
|
|
IL155730A0
(en)
*
|
2000-11-03 |
2003-11-23 |
Biomedicines Inc |
Method for short-term and long-term drug dosimetry
|
|
DK1372708T3
(da)
*
|
2001-02-13 |
2008-10-20 |
Us Gov Sec Army |
Vaccine til transkutan immunisering mod rejsediarre
|
|
US20030060873A1
(en)
*
|
2001-09-19 |
2003-03-27 |
Nanomedical Technologies, Inc. |
Metallic structures incorporating bioactive materials and methods for creating the same
|
|
US7776379B2
(en)
*
|
2001-09-19 |
2010-08-17 |
Medlogics Device Corporation |
Metallic structures incorporating bioactive materials and methods for creating the same
|
|
CA2466228A1
(en)
*
|
2001-11-09 |
2003-08-07 |
Biomedicines, Inc. |
Method for treating diseases with omega interferon
|
|
WO2004028571A2
(en)
*
|
2002-09-27 |
2004-04-08 |
Medlogics Device Corporation |
Implantable stent with modified ends
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
|
ATE448828T1
(de)
*
|
2003-10-27 |
2009-12-15 |
Univ Basel |
Transdermales arzneimittelabgabesystem
|
|
US7208172B2
(en)
*
|
2003-11-03 |
2007-04-24 |
Medlogics Device Corporation |
Metallic composite coating for delivery of therapeutic agents from the surface of implantable devices
|
|
US20050119723A1
(en)
*
|
2003-11-28 |
2005-06-02 |
Medlogics Device Corporation |
Medical device with porous surface containing bioerodable bioactive composites and related methods
|
|
US20060085062A1
(en)
*
|
2003-11-28 |
2006-04-20 |
Medlogics Device Corporation |
Implantable stent with endothelialization factor
|
|
AU2005284908B2
(en)
*
|
2004-09-13 |
2011-12-08 |
Morningside Venture Investments Limited |
Biosynchronous transdermal drug delivery
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
EP1835933A4
(en)
|
2005-01-04 |
2015-01-07 |
Yeda Res & Dev |
HSP60, HSP60-PEPTIDES AND T-CELL VACCINES FOR IMMUNOMODULATION
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
EP1874334A4
(en)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
COMPOSITIONS WITH BETA 2-GLYCOPROTEIN I-PEPTIDES FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES
|
|
WO2006127905A2
(en)
|
2005-05-24 |
2006-11-30 |
Chrono Therapeutics, Inc. |
Portable drug delivery device
|
|
WO2006135785A2
(en)
*
|
2005-06-10 |
2006-12-21 |
Medical College Of Georgia Research Institute |
Compositions and methods for treating immune disorders
|
|
US9446017B2
(en)
|
2005-08-11 |
2016-09-20 |
Augusta University Research Institute, Inc. |
Compositions and methods for treating herpes simplex virus
|
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
|
ATE537826T1
(de)
|
2006-05-16 |
2012-01-15 |
Knopp Neurosciences Inc |
Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
|
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
|
EP2359808B1
(en)
|
2006-08-09 |
2013-05-22 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
|
US9114133B2
(en)
|
2006-08-25 |
2015-08-25 |
U.S. Dept. Of Veterans Affairs |
Method of improving diastolic dysfunction
|
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
|
JP2010521496A
(ja)
|
2007-03-14 |
2010-06-24 |
ノップ ニューロサイエンシーズ、インク． |
キラル精製置換ベンゾチアゾールジアミンの合成
|
|
WO2008133908A2
(en)
|
2007-04-23 |
2008-11-06 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
US20110190356A1
(en)
*
|
2008-08-19 |
2011-08-04 |
Knopp Neurosciences Inc. |
Compositions and Methods of Using (R)- Pramipexole
|
|
AU2010262970A1
(en)
*
|
2009-06-19 |
2012-01-12 |
Knopp Neurosciences, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
|
EP2459184A1
(en)
|
2009-07-31 |
2012-06-06 |
The Brigham and Women's Hospital, Inc. |
Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
|
|
RU2547990C2
(ru)
|
2009-09-28 |
2015-04-10 |
Интарсия Терапьютикс, Инк. |
Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
|
|
EP2556082B1
(en)
|
2010-04-08 |
2017-02-22 |
Emory University |
Substituted androst-4-ene diones
|
|
GB201019761D0
(en)
*
|
2010-11-22 |
2011-01-05 |
Chowdhury Dewan F H |
Multilayered transdermal patch
|
|
EP3513787A1
(en)
|
2011-01-10 |
2019-07-24 |
Invion, Inc |
Use of beta-adrenergic inverse agonists for smoking cessation
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
US9585930B2
(en)
|
2011-03-20 |
2017-03-07 |
Trustees Of Boston University |
Therapeutic agent for emphysema and COPD
|
|
WO2012151474A2
(en)
|
2011-05-04 |
2012-11-08 |
Trustees Of Boston University |
Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
|
|
US20140227293A1
(en)
|
2011-06-30 |
2014-08-14 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
|
EP2543370A1
(en)
|
2011-07-06 |
2013-01-09 |
Georgia Health Sciences University Research Institute, Inc. |
Compositions and Methods for Treating Herpes Simplex Virus
|
|
WO2013006643A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
|
WO2013071049A1
(en)
|
2011-11-10 |
2013-05-16 |
Trustees Of Boston College |
Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
|
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
WO2014130922A1
(en)
|
2013-02-25 |
2014-08-28 |
Trustees Of Boston University |
Compositions and methods for treating fungal infections
|
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
|
EP2999444A4
(en)
|
2013-05-20 |
2016-10-12 |
Mylan Inc |
ADVANCED TRANSDERMAL DOSAGE OF PRAMIPEXOL FOR THE TREATMENT OF NEUROLOGICAL DISEASES
|
|
PL3019167T3
(pl)
|
2013-07-12 |
2021-06-14 |
Knopp Biosciences Llc |
Leczenie podwyższonych poziomów eozynofili i/lub bazofili
|
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
|
DK3033081T3
(da)
|
2013-08-13 |
2021-05-31 |
Knopp Biosciences Llc |
Sammensætninger og fremgangsmåder til behandling af kronisk urticaria
|
|
EP3038467B1
(en)
|
2013-08-13 |
2020-07-29 |
Knopp Biosciences LLC |
Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
|
|
CA2924141C
(en)
|
2013-08-22 |
2022-06-07 |
The General Hospital Corporation |
5-amino 4-cyano substituted oxazole and thiazole derivatives as inhibitors of human 12/15-lipoxygenase
|
|
US11382883B2
(en)
|
2013-08-29 |
2022-07-12 |
Trustees Of Boston University |
Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
|
|
US9937124B2
(en)
|
2014-09-11 |
2018-04-10 |
International Business Machines Corporation |
Microchip substance delivery devices having low-power electromechanical release mechanisms
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
AU2016211330A1
(en)
|
2015-01-28 |
2017-08-03 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
|
US10679516B2
(en)
|
2015-03-12 |
2020-06-09 |
Morningside Venture Investments Limited |
Craving input and support system
|
|
EP3303286B1
(en)
|
2015-06-01 |
2023-10-04 |
Cedars-Sinai Medical Center |
Compounds that bind to rela of nf-kb for use in treating cancer
|
|
RU2730996C2
(ru)
|
2015-06-03 |
2020-08-26 |
Интарсия Терапьютикс, Инк. |
Системы установки и извлечения имплантата
|
|
CN108349968A
(zh)
|
2015-07-28 |
2018-07-31 |
维奥梅生物科学私人有限公司 |
抗菌治疗剂和预防剂
|
|
US10881788B2
(en)
|
2015-10-30 |
2021-01-05 |
International Business Machines Corporation |
Delivery device including reactive material for programmable discrete delivery of a substance
|
|
KR102574993B1
(ko)
|
2016-05-16 |
2023-09-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
JP7286542B2
(ja)
|
2017-01-03 |
2023-06-05 |
インターシア セラピューティクス，インコーポレイティド |
Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
|
|
CA3049529A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
US12397141B2
(en)
|
2018-11-16 |
2025-08-26 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|